Since 2012, we have been setting standards in the fields of cybersecurity, artificial intelligence, and e-health.
Our operations are based on a strong strategy with defined objectives. It is built on three fundamental pillars: “beyond the edge,” “future-proof skills,” and “effective delivery.”
Discover the 3 Key Markets We Will Focus on in 2024 – 2025:
Leading edge solutions for tomorrow
We deliver pioneering solutions that anticipate future needs, always with a focus on secure and effective implementations.
Leveraging insights from the development and implementation of Cyrima, we will offer cybersecurity consulting services, with or without our tool. These services will cater to clients in regulated markets, including the e-health sector.
To derive a significant portion of SEDIVIO SA’s annual revenue from cybersecurity, through consulting services and the sale of our proprietary Cyrima system. We aim for rapid annual growth in this sector’s revenues.
We plan to acquire at least 200 clients for the Cyrima system, with approximately 50% from outside the Polish market. Additionally, we will continue to enhance the product to meet evolving market conditions and legislative requirements.
Revolutionizing software development
AI is revolutionizing software development through automation, testing, data analysis, and project management. It rapidly generates code, automates tests, analyzes data, and supports management processes, making it a crucial development area for the IT market.
In our past projects, we have extensively utilized AI-based solutions for software development automation and testing. By integrating market-available tools with our proprietary solutions, we have achieved significant advancements.
We now aim to leverage this experience to build a new service centered on integrating AI solutions for our clients, including SMEs.
By the end of 2025, we plan to achieve our first revenues from the sale of services based on implementing AI solutions for our clients.
Our field of expertise
With a decade of collaboration in the medical industry, we provide robust and comprehensive solutions that elevate healthcare standards and protect patient data. We have developed or co-developed IT systems used by millions of users.
In 2023 alone, we signed two framework agreements with the governmental Center for e-Health, totaling over 30 million PLN.
Currently, we plan to expand our team responsible for handling public contracts and recruiting IT specialists. This initiative will further solidify our position as an independent IT service provider for state administration entities in the e-health market.
Increase revenue from our core activity, which is handling large public contracts in the e-health sector. We aim for a double-digit growth rate in revenues from this area.
Leading edge solutions for tomorrow
We deliver pioneering solutions that anticipate future needs, always with a focus on secure and effective implementations.
Leveraging insights from the development and implementation of Cyrima, we will offer cybersecurity consulting services, with or without our tool. These services will cater to clients in regulated markets, including the e-health sector.
To derive a significant portion of SEDIVIO SA’s annual revenue from cybersecurity, through consulting services and the sale of our proprietary Cyrima system. We aim for rapid annual growth in this sector’s revenues.
We plan to acquire at least 200 clients for the Cyrima system, with approximately 50% from outside the Polish market. Additionally, we will continue to enhance the product to meet evolving market conditions and legislative requirements.
Revolutionizing software development
AI is revolutionizing software development through automation, testing, data analysis, and project management. It rapidly generates code, automates tests, analyzes data, and supports management processes, making it a crucial development area for the IT market.
In our past projects, we have extensively utilized AI-based solutions for software development automation and testing. By integrating market-available tools with our proprietary solutions, we have achieved significant advancements.
We now aim to leverage this experience to build a new service centered on integrating AI solutions for our clients, including SMEs.
By the end of 2025, we plan to achieve our first revenues from the sale of services based on implementing AI solutions for our clients.
Our field of expertise
With a decade of collaboration in the medical industry, we provide robust and comprehensive solutions that elevate healthcare standards and protect patient data. We have developed or co-developed IT systems used by millions of users.
In 2023 alone, we signed two framework agreements with the governmental Center for e-Health, totaling over 30 million PLN.
Currently, we plan to expand our team responsible for handling public contracts and recruiting IT specialists. This initiative will further solidify our position as an independent IT service provider for state administration entities in the e-health market.
Increase revenue from our core activity, which is handling large public contracts in the e-health sector. We aim for a double-digit growth rate in revenues from this area.
We focus on delivering value for investors and shareholders. The results of our work are evidenced by the company’s stable financial situation, built on core operations. This stability allows us to pursue dynamic growth in new areas with particularly high development potential.
The NewConnect market segments aim to increase transparency and help investors assess the financial health of companies, making it easier to understand the associated financial risks. Our company has been classified into the NC Focus segment.
Source and more information: https://newconnect.pl/market-segments
The shares have been listed on the NewConnect market for at least 12 months;
The average share price is higher than 10 groszy;
The book value of the issuer, as shown in the latest published periodic report, is not negative;
The issuer is not undergoing bankruptcy, arrangement, restructuring, or liquidation proceedings;
In the last 12 months, no more than one disciplinary measure provided for in the ASO Regulations has been imposed on the issuer;
In the last 3 months, no disciplinary measures provided for in the ASO Regulations have been imposed on the issuer, nor has trading in its shares been suspended for the safety of trading participants.
The average market capitalization of the issuer exceeds 12,000,000 PLN;
The price/earnings ratio is higher than 0 and lower than 50;
The price/book value ratio is higher than 0 and lower than 10;
The dividend yield is higher than 0 (the company has paid a dividend);
The book value exceeds 1,000,000 PLN;
Positive revenue growth over the last 4 quarters;
Positive net profit growth over the last 4 quarters.
Our daily work is made possible by the trust of our investors and shareholders. We are pleased that they believe in SEDIVIO SA.
Shareholders holding shares entitling them to at least 5% of votes at the General Meeting by share of the total number of votes:
| Shareholder | Number of Shares | Number of Votes | Share in Share Capital | Share in Total Votes |
|---|---|---|---|---|
| Barczewscy Fundacja Rodzinna | 812 001 | 812 001 | 26,67% | 26,67% |
Karol Matczak | 173 742 | 173 742 | 5,71% | 5,71% |
| Others | 2 059 253 | 2 059 253 | 60,93% | 60,93% |
If you have any questions, get in touch with us.
We will respond as quickly as possible!
CFO, Investor Relations
ul. Okopowa 47/23
01-059 Warsaw
If you have any questions, get in touch with us. We will respond as quickly as possible!
Privacy Policy
Click here to read SEDIVIO’s Privacy Policy.
ul. Okopowa 47/23
01-059 Warsaw
Tel: +48 226022530
E-mail: office@sedivio.com
Tax Identification Number: 521-34-10-954